Cardiol Therapeutics Class Stock Price on November 29, 2024
| CRDL Stock | USD 1.62 0.04 2.53% |
Below is the normalized historical share price chart for Cardiol Therapeutics Class extending back to January 15, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cardiol Therapeutics stands at 1.62, as last reported on the 29th of November, with the highest price reaching 1.66 and the lowest price hitting 1.57 during the day.
If you're considering investing in Cardiol Stock, it is important to understand the factors that can impact its price. Cardiol Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0584, which signifies that the company had a -0.0584% return per unit of risk over the last 3 months. Cardiol Therapeutics Class exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cardiol Therapeutics' Standard Deviation of 3.75, mean deviation of 2.91, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
At this time, Cardiol Therapeutics' Total Stockholder Equity is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 38.6 M this year, although the value of Other Stockholder Equity will most likely fall to about 10 M. . The value of Price To Sales Ratio is estimated to slide to 1,023. The value of Price Earnings Ratio is estimated to slide to -2.65. Cardiol Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of January 2019 | 200 Day MA 1.962 | 50 Day MA 1.9208 | Beta 0.697 |
Cardiol |
Sharpe Ratio = -0.0584
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRDL |
Estimated Market Risk
| 3.8 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cardiol Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiol Therapeutics by adding Cardiol Therapeutics to a well-diversified portfolio.
Price Book 16.7873 | Enterprise Value Ebitda 0.298 | Price Sales 1.1 K | Shares Float 66.6 M | Wall Street Target Price 12.4228 |
Cardiol Therapeutics Valuation on November 29, 2024
It is possible to determine the worth of Cardiol Therapeutics on a given historical date. On November 29, 2024 Cardiol was worth 1.59 at the beginning of the trading date compared to the closed value of 1.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardiol Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cardiol Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardiol Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardiol Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.53 | 1.60 | 1.49 | 1.58 | 0.00 | |
11/29/2024 | 1.59 | 1.66 | 1.57 | 1.62 | 285,282 |
| Backtest Cardiol Therapeutics | | | Cardiol Therapeutics History | | | Cardiol Therapeutics Valuation | Previous |
Cardiol Therapeutics Trading Date Momentum on November 29, 2024
| On November 29 2024 Cardiol Therapeutics Class was traded for 1.62 at the closing time. The top price for the day was 1.66 and the lowest listed price was 1.57 . The trading volume for the day was 285.3 K. The trading history from November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.85% . |
Cardiol Therapeutics Fundamentals Correlations and Trends
By evaluating Cardiol Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardiol Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardiol financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cardiol Therapeutics Stock history
Cardiol Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardiol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardiol Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardiol Therapeutics stock prices may prove useful in developing a viable investing in Cardiol Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.5 M | 41.5 M | |
| Net Loss | -27.8 M | -29.2 M |
Cardiol Therapeutics Quarterly Net Working Capital |
|
Cardiol Therapeutics Stock Technical Analysis
Cardiol Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cardiol Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Cardiol Therapeutics Class cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cardiol Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By undertsting and applying Cardiol Therapeutics stock market strength indicators, traders can identify Cardiol Therapeutics Class entry and exit signals to maximize returns
Cardiol Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardiol Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cardiol Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardiol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. If investors know Cardiol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiol Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Return On Assets (0.54) | Return On Equity (1.08) |
The market value of Cardiol Therapeutics is measured differently than its book value, which is the value of Cardiol that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiol Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cardiol Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiol Therapeutics' market value can be influenced by many factors that don't directly affect Cardiol Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.